An epigenetic reprogramming company co-founded by Brian Armstrong.
AI-generated insights about New Limit from various financial sources
Uses AI to computationally solve the discovery process for cellular reprogramming; highlighted as a key company in the longevity sector.
Part of a wave of high-profile longevity startups backed by major tech billionaires.
Uses AI to computationally solve the discovery process for cellular reprogramming; highlighted as a key company in the longevity sector.
Part of a wave of high-profile longevity startups backed by major tech billionaires.